Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy Agents.
Sun C, Cheng Y, Dong J, Hu L, Zhang Y, Shen H, Zhang G, Jiang B, Adam Youssouf S, Min W, Shen Y, Wang L, Deng H, Xiao Y, Yang P.
Sun C, et al. Among authors: cheng y.
J Med Chem. 2024 Dec 28. doi: 10.1021/acs.jmedchem.4c01640. Online ahead of print.
J Med Chem. 2024.
PMID: 39731560